- Home
- QTRX
as 05-09-2025 4:00pm EST
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
Upcoming Earnings Alert:
Get ready for potential market movements as Quanterix Corporation QTRX prepares to release earnings report on 12 May 2025.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | 223.6M | IPO Year: | 2017 |
| Target Price: | $16.20 | AVG Volume (30 days): | 603.8K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.67 - $19.18 | Next Earning Date: | 05-12-2025 |
| Revenue: | $137,421,000 | Revenue Growth: | 12.30% |
| Revenue Growth (this year): | 5.22% | Revenue Growth (next year): | 15.31% |
Latest Quanterix Corporation News
QTRX Breaking Stock News: Dive into QTRX Ticker-Specific Updates for Smart Investing
GuruFocus.com
11 hours ago
Earnings To Watch: Quanterix Corp (QTRX) Reports Q1 2025 Result
Business Wire
5 days ago
Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025
Business Wire
10 days ago
Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders
MT Newswires
10 days ago
Quanterix, Akoya Biosciences Amend Merger Deal
Business Wire
11 days ago
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
Simply Wall St.
11 days ago
Strong week for Quanterix (NASDAQ:QTRX) shareholders doesn't alleviate pain of five-year loss
Business Wire
23 days ago
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
Business Wire
a month ago
Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya
Compare QTRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QTRX Quanterix Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.